Latest Production News

Arafura Rare Earths has secured a binding offtake term sheet with Traxys North America to supply 500 tonnes per annum of NdPr oxide, underpinning its Nolans Project and supporting US critical minerals supply chains.

Barminco, Perenti's underground mining arm, has landed a significant A$850 million contract at Bellevue Gold Project, expanding its Australian footprint and requiring A$75 million growth capital in FY27.

Genmin has drawn strong international interest to finance its Baniaka iron ore project in Gabon, with proposals ranging from joint ventures to prepayment facilities. The Gabonese government backs the project as a national priority, aiming for a final investment decision by mid-2026.

Commonwealth Bank of Australia reported a steady cash profit of around $2.7 billion in 3Q26, balancing disciplined lending growth and cautious provisioning amid geopolitical and economic uncertainties.

Barramundi Limited outperformed the S&P/ASX200 in April with a 4.4% gross return, boosted by NEXT DC’s landmark data centre deal and capital raise, while healthcare stocks faced headwinds from Cochlear’s profit downgrade.

Kingfish Limited’s portfolio edged higher in April, buoyed by strong performances from Mercury and Infratil, while a2 Milk and Summerset weighed on returns amid operational and economic headwinds.

AoFrio’s first quarter revenue plunged 28% year-on-year, weighed down by the loss of a major US motor customer amid tariffs. The refrigeration tech firm is banking on new IoT product launches in Q2 to stabilise sales and improve profitability over 2026.

Radius Residential Care delivered a standout FY26 with profit before tax surging 37% to $14.3 million, a 50% hike in its final dividend, and growth fueled by acquisitions and new developments.

Tartana Minerals revises its corporate presentation to clarify prior disclosures while spotlighting a $4.5 million capital raise to boost copper sulphate production and expand drilling across its Far North Queensland portfolio.

Legacy Minerals has withdrawn its earlier Mt Carrington production targets, updating its Scoping Study to reflect a stronger basis with 71% Indicated Resources. The revised study outlines a 12-year mine life, A$514 million pre-tax NPV7, and a streamlined development plan.

Zimi Limited has increased its placement commitments by A$100,000 from a sophisticated investor, bringing total funds raised to A$1.56 million ahead of shareholder approval.

Avecho Biotechnology has bolstered its cash reserves by $1.9 million through the exercise of listed options, positioning the company for a pivotal Phase III interim analysis readout for its insomnia treatment.